We adopted an automated method for measuring guanase in donor blood and examined the incidence of posttransfusional non-A, non-B hepatitis when donor blood with high guanase activities was excluded. Sixtyseven (2.4%) of 2,826 units were excluded from use in transfusion because they had guanase activ
Prevention of posttransfusional non-A, non-B hepatitis using the screening test for guanase activity of donor blood
β Scribed by Ito, Susumu ;Tsuji, Yasuhiro
- Publisher
- Springer-Verlag
- Year
- 1988
- Tongue
- English
- Weight
- 483 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0435-1339
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
A total of 107 recipients, who did not show any evidence of hepatic disorders in pretransfusional liver function tests and gave a negative reaction for HBsAg, were observed from 3 weeks to 3 months after blood transfusion of 71 1 units of blood. The blood was judged suitable for use in transfusion b
heart surgery at out institution were prospectively studied. Inclusion crit,eria were the following: absence of transfusion or acute hepatitis during the prior year, alcohol intake <80 gm per day. absence of the use of hepatotoxic drugs, normal aminotransferase values and negative hepatitis B virus